JPRN-UMIN000033322
Recruiting
未知
The multicenter clinical trial to investigate the safety and efficacy of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis - The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis
Conditionsgastrointestinal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- gastrointestinal cancer
- Sponsor
- Kyoto University
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Hyperammonemia within 14 days before registration. 2\) Peripheral sensory neuropathy Grade 2 (evaluated in CTCAE v 4\.0\) or more. 3\) Oral administration of warfarin is necessary. 4\) During peritoneal dialysis. 5\) Cirrhosis (Child\-Pugh B, C) 6\) Symptoms that suspect encephalopathy such as gait disturbance and language disorder. 7\) Patients refused to participate in this study. 8\) The doctor judged inappropriate to register for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysisEsophageal cancer, gastric cancer, small bowel cancer, colorectal cancerJPRN-jRCTs051190120Manabu Muto15
Completed
Not Applicable
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Breast CancerCancer - BreastACTRN12623000205639OncoRes Medical Pty Ltd30
Active, not recruiting
Not Applicable
An open multicenter clinical trial to evaluate the safety, tolerability and efficacy of Deferasirox (ICL670) in patients affected by Myelodysplastic syndrome and transfusional chronic hemosiderosis. - GIMEMA MDS 0306ow and intermediate I risk (IPSS score) Myelodysplastic syndrome and transfusion-induced hemosiderosis.MedDRA version: 9.1Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2006-006147-31-ITG.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
Not yet recruiting
Not Applicable
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
Active, not recruiting
Not Applicable
A multi-center, open-label trial to investigate the safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures with or without secondary generalization.partial seizures with or without secondary generalizationMedDRA version: 6.0Level: LLTClassification code 10034089EUCTR2004-002322-22-DESCHWARZ BIOSCIENCES Inc.160